Paper35575255
Chemical Approaches to Synthetic Drug Delivery Systems for Systemic Applications.
Braatz D and 9 others. Angew Chem Int Ed Engl, 2022. Cited by 46 papers, by iCite.
Cite this record
ConductScience Library. Chemical Approaches to Synthetic Drug Delivery Systems for Systemic Applications. Papers, record 35575255. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35575255
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Drug Delivery Systems | Major topic |
| Polymers | Major topic |
| Solubility | |
| Pharmaceutical Preparations | |
| Water |
Source PubMed
References234
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 17636564 | Mechanism of action of certolizumab pegol (CDP870): in vitro comparison with other anti-tumor necrosis factor alpha agents. | Inflamm Bowel Dis | 2007 | https://conductscience.org/library/papers/17636564 | PubMed |
| 2 | 16219368 | Evaluation of dendrimer SPL7013, a lead microbicide candidate against herpes simplex viruses. | Antiviral Res | 2005 | https://conductscience.org/library/papers/16219368 | PubMed |
| 3 | 21818161 | Stability of Self-Assembled Polymeric Micelles in Serum. | Macromolecules | 2011 | https://conductscience.org/library/papers/21818161 | PubMed |
| 4 | 29313017 | Anticancer nanoparticulate polymer-drug conjugate. | Bioeng Transl Med | 2016 | https://conductscience.org/library/papers/29313017 | PubMed |
| 5 | 11335787 | Phase I clinical and pharmacokinetic study of PNU166945, a novel water-soluble polymer-conjugated prodrug of paclitaxel. | Anticancer Drugs | 2001 | https://conductscience.org/library/papers/11335787 | PubMed |
| 6 | 18680439 | Application of dendrimer-drug complexation in the enhancement of drug solubility and bioavailability. | Expert Opin Drug Metab Toxicol | 2008 | https://conductscience.org/library/papers/18680439 | PubMed |
| 7 | 405385 | Alteration of immunological properties of bovine serum albumin by covalent attachment of polyethylene glycol. | J Biol Chem | 1977 | https://conductscience.org/library/papers/405385 | PubMed |
| 8 | 10699287 | Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. | J Control Release | 2000 | https://conductscience.org/library/papers/10699287 | PubMed |
| 9 | 27439953 | A Modular Method for the High-Yield Synthesis of Site-Specific Protein-Polymer Therapeutics. | Angew Chem Int Ed Engl | 2016 | https://conductscience.org/library/papers/27439953 | PubMed |
| 10 | 18475293 | Phase III trial comparing paclitaxel poliglumex vs docetaxel in the second-line treatment of non-small-cell lung cancer. | Br J Cancer | 2008 | https://conductscience.org/library/papers/18475293 | PubMed |
| 11 | 21040218 | Improved anti-tumor activity of stabilized anthracycline polymeric micelle formulation, NC-6300. | Cancer Sci | 2011 | https://conductscience.org/library/papers/21040218 | PubMed |
| 12 | 19671439 | ProLindac (AP5346): a review of the development of an HPMA DACH platinum Polymer Therapeutic. | Adv Drug Deliv Rev | 2009 | https://conductscience.org/library/papers/19671439 | PubMed |
| 13 | 33792290 | Polyglycerol for Half-Life Extension of Proteins-Alternative to PEGylation? | Biomacromolecules | 2021 | https://conductscience.org/library/papers/33792290 | PubMed |
| 14 | 23020861 | Influence of architecture of high molecular weight linear and branched polyglycerols on their biocompatibility and biodistribution. | Biomaterials | 2012 | https://conductscience.org/library/papers/23020861 | PubMed |
| 15 | 27369864 | Anti-PEG antibodies in the clinic: Current issues and beyond PEGylation. | J Control Release | 2016 | https://conductscience.org/library/papers/27369864 | PubMed |
| 16 | 16862189 | Drug penetration in solid tumours. | Nat Rev Cancer | 2006 | https://conductscience.org/library/papers/16862189 | PubMed |
| 17 | 19084037 | Polymersome delivery of siRNA and antisense oligonucleotides. | J Control Release | 2009 | https://conductscience.org/library/papers/19084037 | PubMed |
| 18 | 21297034 | Sortase-catalyzed transformations that improve the properties of cytokines. | Proc Natl Acad Sci U S A | 2011 | https://conductscience.org/library/papers/21297034 | PubMed |
| 19 | 31310511 | Enzyme-Activatable Interferon-Poly(α-amino acid) Conjugates for Tumor Microenvironment Potentiation. | Biomacromolecules | 2019 | https://conductscience.org/library/papers/31310511 | PubMed |
| 20 | 24056901 | Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology. | Nat Nanotechnol | 2013 | https://conductscience.org/library/papers/24056901 | PubMed |
Cited by20
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 46 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42259798 | Supercharged ferritin nanocages enable universal cytosolic protein delivery. | Nat Commun | 2026 | https://conductscience.org/library/papers/42259798 | PubMed |
| 42204141 | Combating small extracellular vesicle-mediated immunological barriers in the tumor microenvironment via strategically activatable PEGylated peptides. | Signal Transduct Target Ther | 2026 | https://conductscience.org/library/papers/42204141 | PubMed |
| 41477338 | Site-specific PEGylation of proteins: Insights into structural and functional changes. | Acta Pharm Sin B | 2025 | https://conductscience.org/library/papers/41477338 | PubMed |
| 40565229 | Peptide-Engineered Seliciclib Nanomedicine for Brain-Targeted Delivery and Neuroprotection. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40565229 | PubMed |
| 40459969 | Hydration Contribution to the Solvation Free Energy of Water-Soluble Polymers. | J Phys Chem B | 2025 | https://conductscience.org/library/papers/40459969 | PubMed |
| 39959040 | Novel Maleimide Linkers Based on a Piperazine Motif for Strongly Increased Aqueous Solubility. | ACS Omega | 2025 | https://conductscience.org/library/papers/39959040 | PubMed |
| 39664427 | Solubilization techniques used for poorly water-soluble drugs. | Acta Pharm Sin B | 2024 | https://conductscience.org/library/papers/39664427 | PubMed |
| 39642424 | Advances in acid-degradable and enzyme-cleavable linkers for drug delivery. | Curr Opin Chem Biol | 2025 | https://conductscience.org/library/papers/39642424 | PubMed |
| 39493304 | Extracellular vesicle mimetics as delivery vehicles for oligonucleotide-based therapeutics and plasmid DNA. | Front Bioeng Biotechnol | 2024 | https://conductscience.org/library/papers/39493304 | PubMed |
| 38543448 | Polymer-Based Drug Delivery Systems for Cancer Therapeutics. | Polymers (Basel) | 2024 | https://conductscience.org/library/papers/38543448 | PubMed |
| 38333874 | d-α-tocopheryl polyethylene glycol 1000 succinate surface scaffold polysarcosine based polymeric nanoparticles of enzalutamide for the treatment of colorectal cancer: In vitro, in vivo characterizations. | Heliyon | 2024 | https://conductscience.org/library/papers/38333874 | PubMed |
| 37908727 | Peptide-drug co-assembling: A potent armament against cancer. | Theranostics | 2023 | https://conductscience.org/library/papers/37908727 | PubMed |
| 37836823 | Optimization and Characterization of Sodium Alginate Beads Providing Extended Release for Antidiabetic Drugs. | Molecules | 2023 | https://conductscience.org/library/papers/37836823 | PubMed |
| 37765191 | Hyperbranched Polymers: Recent Advances in Photodynamic Therapy against Cancer. | Pharmaceutics | 2023 | https://conductscience.org/library/papers/37765191 | PubMed |
| 37563117 | Applied machine learning as a driver for polymeric biomaterials design. | Nat Commun | 2023 | https://conductscience.org/library/papers/37563117 | PubMed |
| 37500621 | Precise cooperative sulfur placement leads to semi-crystallinity and selective depolymerisability in CS2/oxetane copolymers. | Nat Commun | 2023 | https://conductscience.org/library/papers/37500621 | PubMed |
| 37402278 | Polyglycerol-Based Biomedical Matrix for Immunomagnetic Circulating Tumor Cell Isolation and Their Expansion into Tumor Spheroids for Drug Screening. | Adv Healthc Mater | 2023 | https://conductscience.org/library/papers/37402278 | PubMed |
| 37261292 | Tailoring thermoresponsiveness of biocompatible polyethers: copolymers of linear glycerol and ethyl glycidyl ether. | Polym Chem | 2023 | https://conductscience.org/library/papers/37261292 | PubMed |
| 36771924 | Conformational Parameters and Hydrodynamic Behavior of Poly(2-Methyl-2-Oxazoline) in a Broad Molar Mass Range. | Polymers (Basel) | 2023 | https://conductscience.org/library/papers/36771924 | PubMed |
| 35575255 | Chemical Approaches to Synthetic Drug Delivery Systems for Systemic Applications. | Angew Chem Int Ed Engl | 2022 | https://conductscience.org/library/papers/35575255 | PubMed |
Genes22
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35575255
GET https://conductscience.org/api/papers/v1/35575255/references?page=2